Chinese Journal of Dermatology ›› 2025, Vol. 58 ›› Issue (7): 583-590.doi: 10.35541/cjd.20250092
• Guidelines and Consensus • Previous Articles Next Articles
Hair Research Group, Chinese Society of Dermatology
Received:
2025-02-24
Revised:
2025-05-12
Online:
2025-07-15
Published:
2025-07-03
Contact:
Wu Wenyu; Zhou Cheng
E-mail:wenyu_wu@fudan.edu.cn; chengzhou@live.cn
Supported by:
Hair Research Group, Chinese Society of Dermatology. Chinese expert consensus on the diagnosis and treatment of lichen planopilaris/frontal fibrosing alopecia (2025 edition)[J]. Chinese Journal of Dermatology, 2025, 58(7): 583-590.doi:10.35541/cjd.20250092
[1] | Ross EK, Tan E, Shapiro J. Update on primary cicatricial alopecias[J]. J Am Acad Dermatol, 2005,53(1):1⁃37; quiz 38⁃40. doi: 10.1016/j.jaad.2004.06.015. |
[2] | Sundberg JP, Hordinsky MK, Bergfeld W, et al. Cicatricial alopecia research foundation meeting, May 2016: progress towards the diagnosis, treatment and cure of primary cicatricial alopecias[J]. Exp Dermatol, 2018,27(3):302⁃310. doi: 10.1111/exd.13495. |
[3] | Hordinsky M. Scarring alopecia: diagnosis and new treatment options[J]. Dermatol Clin, 2021,39(3):383⁃388. doi: 10.1016/j.det.2021.05.001. |
[4] | Joshi TP, Zhu H, Naqvi Z, et al. Prevalence of lichen planopilaris in the United States: a cross⁃sectional study of the All of Us research program[J]. JAAD Int, 2022,8:69⁃70. doi: 10.1016/j.jdin.2022.05.003. |
[5] | Porriño⁃Bustamante ML, Fernández⁃Pugnaire MA, Arias⁃Santiago S. Frontal fibrosing alopecia: a review[J]. J Clin Med, 2021,10(9):1805. doi: 10.3390/jcm10091805. |
[6] | Hajizadeh N, Heidari A, Sadeghi S, et al. Tumor necrosis factor inhibitors and janus kinase inhibitors in the treatment of cicatricial alopecia: a systematic review[J]. PLoS One, 2024,19(2):e0293433. doi: 10.1371/journal.pone.0293433. |
[7] | Tavakolpour S, Mahmoudi H, Abedini R, et al. Frontal fibrosing alopecia: an update on the hypothesis of pathogenesis and treatment[J]. Int J Womens Dermatol, 2019,5(2):116⁃123. doi: 10.1016/j.ijwd.2018.11.003. |
[8] | Tziotzios C, Petridis C, Dand N, et al. Genome⁃wide association study in frontal fibrosing alopecia identifies four susceptibility loci including HLA⁃B*07:02[J]. Nat Commun, 2019,10(1):1150. doi: 10.1038/s41467⁃019⁃09117⁃w. |
[9] | Miao YJ, Jing J, Du XF, et al. Frontal fibrosing alopecia: a review of disease pathogenesis[J]. Front Med (Lausanne), 2022,9:911944. doi: 10.3389/fmed.2022.911944. |
[10] | Prasad S, Marks DH, Burns LJ, et al. Patch testing and contact allergen avoidance in patients with lichen planopilaris and/or frontal fibrosing alopecia: a cohort study[J]. J Am Acad Dermatol, 2020,83(2):659⁃661. doi: 10.1016/j.jaad.2020.01.026. |
[11] | Dubin C, Glickman JW, Del Duca E, et al. Scalp and serum profiling of frontal fibrosing alopecia reveals scalp immune and fibrosis dysregulation with no systemic involvement[J]. J Am Acad Dermatol, 2022,86(3):551⁃562. doi: 10.1016/j.jaad.2021. 05.016. |
[12] | Yang CC, Khanna T, Sallee B, et al. Tofacitinib for the treatment of lichen planopilaris: a case series[J]. Dermatol Ther, 2018,31(6):e12656. doi: 10.1111/dth.12656. |
[13] | Fechine C, Valente N, Romiti R. Lichen planopilaris and frontal fibrosing alopecia: review and update of diagnostic and therapeutic features[J]. An Bras Dermatol, 2022,97(3):348⁃357. doi: 10.1016/j.abd.2021.08.008. |
[14] | Dunn C, Griffith V, Coican A, et al. Janus kinase inhibition for the treatment of refractory frontal fibrosing alopecia: a case series and review of the literature[J]. JAAD Case Rep, 2023,40:47⁃52. doi: 10.1016/j.jdcr.2023.07.037. |
[15] | Moussa A, Bhoyrul B, Asfour L, et al. Treatment of lichen planopilaris with baricitinib: a retrospective study[J]. J Am Acad Dermatol, 2022,87(3):663⁃666. doi: 10.1016/j.jaad.2022. 02.027. |
[16] | Plante J, Eason C, Snyder A, et al. Tofacitinib in the treatment of lichen planopilaris: a retrospective review[J]. J Am Acad Dermatol, 2020,83(5):1487⁃1489. doi: 10.1016/j.jaad.2020.05. 104. |
[17] | Rácz E, Gho C, Moorman PW, et al. Treatment of frontal fibrosing alopecia and lichen planopilaris: a systematic review[J]. J Eur Acad Dermatol Venereol, 2013,27(12):1461⁃1470. doi: 10.1111/jdv.12139. |
[18] | Holmes S, Ryan T, Young D, et al. Frontal Fibrosing Alopecia Severity Index (FFASI): a validated scoring system for assessing frontal fibrosing alopecia[J]. Br J Dermatol, 2016,175(1):203⁃207. doi: 10.1111/bjd.14445. |
[19] | Vañó⁃Galván S, Molina⁃Ruiz AM, Serrano⁃Falcón C, et al. Frontal fibrosing alopecia: a multicenter review of 355 patients[J]. J Am Acad Dermatol, 2014,70(4):670⁃678. doi: 10.1016/j.jaad.2013.12.003. |
[20] | Price VH. The medical treatment of cicatricial alopecia[J]. Semin Cutan Med Surg, 2006,25(1):56⁃59. doi: 10.1016/j.sder.2006.01.008. |
[21] | Mahmoudi H, Rostami A, Tavakolpour S, et al. Oral isotretinoin combined with topical clobetasol 0.05% and tacrolimus 0.1% for the treatment of frontal fibrosing alopecia: a randomized controlled trial[J]. J Dermatolog Treat, 2022,33(1):284⁃290. doi: 10.1080/09546634.2020.1750553. |
[22] | Imhof R, Tolkachjov SN. Optimal management of frontal fibrosing alopecia: a practical guide[J]. Clin Cosmet Investig Dermatol, 2020,13:897⁃910. doi: 10.2147/CCID.S235980. |
[23] | Pindado⁃Ortega C, Pirmez R, Melo DF, et al. Low⁃dose oral minoxidil for frontal fibrosing alopecia: a 122⁃patient case series[J]. Actas Dermosifiliogr, 2025,116(4):T407⁃T411. doi: 10. 1016/j.ad.2025.02.008. |
[24] | Ly N, McClure EM, Hordinsky MK, et al. Safety and efficacy of minoxidil treatment in scarring alopecia: a scoping review[J]. J Drugs Dermatol, 2024,23(3):146⁃151. doi: 10.36849/jdd.7743. |
[25] | Chen LC, Ogbutor C, Kelley KJ, et al. Topical tofacitinib for patients with lichen planopilaris and/or frontal fibrosing alopecia[J]. J Am Acad Dermatol, 2024,90(6):1260⁃1262. doi: 10.1016/j.jaad.2024.01.060. |
[26] | Williams KN, Perez SM, Burroway B, et al. Topical ruxolitinib in the management of frontal fibrosing alopecia and/or lichen planopilaris: a single⁃center retrospective cohort study[J]. J Am Acad Dermatol, 2025,92(1):170⁃172. doi: 10.1016/j.jaad.2024. 09.032. |
[27] | Chiang C, Sah D, Cho BK, et al. Hydroxychloroquine and lichen planopilaris: efficacy and introduction of Lichen Planopilaris Activity Index scoring system[J]. J Am Acad Dermatol, 2010,62(3):387⁃392. doi: 10.1016/j.jaad.2009.08.054. |
[28] | Strazzulla LC, Avila L, Li X, et al. Prognosis, treatment, and disease outcomes in frontal fibrosing alopecia: a retrospective review of 92 cases[J]. J Am Acad Dermatol, 2018,78(1):203⁃205. doi: 10.1016/j.jaad.2017.07.035. |
[29] | Mesinkovska NA, Tellez A, Dawes D, et al. The use of oral pioglitazone in the treatment of lichen planopilaris[J]. J Am Acad Dermatol, 2015,72(2):355⁃356. doi: 10.1016/j.jaad.2014. 10.036. |
[30] | Peterson EL, Gutierrez D, Brinster NK, et al. Response of lichen planopilaris to pioglitazone hydrochloride[J]. J Drugs Dermatol, 2019,18(12):1276⁃1279. |
[31] | Seo HM, Oh SU, Kim S, et al. Dutasteride in the treatment of frontal fibrosing alopecia: systematic review and meta⁃analysis[J]. J Eur Acad Dermatol Venereol, 2024,38(8):1514⁃1521. doi: 10.1111/jdv.19802. |
[32] | Vano⁃Galvan S, Saceda⁃Corralo D. Oral dutasteride is a first⁃line treatment for frontal fibrosing alopecia[J]. J Eur Acad Dermatol Venereol, 2024,38(8):1455⁃1456. doi: 10.1111/jdv.20174. |
[33] | Fatemi F, Mohaghegh F, Danesh F, et al. Isotretinoin for the treatment of facial lichen planopilaris: a new indication for an old drug, a case series study[J]. Clin Case Rep, 2020,8(12):2524⁃2529. doi: 10.1002/ccr3.3210. |
[34] | Cranwell WC, Sinclair R. Familial frontal fibrosing alopecia treated with dutasteride, minoxidil and artificial hair transplantation[J]. Australas J Dermatol, 2017,58(3):e94⁃e96. doi: 10.1111/ajd.12499. |
[35] | Vañó⁃Galván S, Villodres E, Pigem R, et al. Hair transplant in frontal fibrosing alopecia: a multicenter review of 51 patients[J]. J Am Acad Dermatol, 2019,81(3):865⁃866. doi: 10.1016/j.jaad.2019.05.031. |
[36] | Pathoulas JT, Flanagan KE, Su MY, et al. A prospective pilot study of narrowband UV⁃B treatment of lichen planopilaris[J]. J Am Acad Dermatol, 2022,87(3):703⁃705. doi: 10.1016/j.jaad. 2022.04.054. |
[37] | Subash J, Eginli A, Bomar L, et al. Frontal fibrosing alopecia treatment with Nd:YAG (1064 nm) nonablative laser[J]. Int J Womens Dermatol, 2021,7(3):355⁃356. doi: 10.1016/j.ijwd. 2020.10.007. |
[38] | Navarini AA, Kolios AG, Prinz⁃Vavricka BM, et al. Low⁃dose excimer 308⁃nm laser for treatment of lichen planopilaris[J]. Arch Dermatol, 2011,147(11):1325⁃1326. doi: 10.1001/archdermatol.2011.335. |
[39] | Vañó⁃Galván S, Trindade de Carvalho L, Saceda⁃Corralo D, et al. Oral minoxidil improves background hair thickness in lichen planopilaris[J]. J Am Acad Dermatol, 2021,84(6):1684⁃1686. doi: 10.1016/j.jaad.2020.04.026. |
[1] | Sha Yuou, Wei Kelu, Lin Jinran, Liu Qingmei, Ni Chunya, Wu Wenyu, . Fibrosing alopecia in a pattern distribution [J]. Chinese Journal of Dermatology, 2025, 58(7): 660-663. |
[2] | Sun Jiayi, Song Xiuzu. Autophagy in hair physiology and pathology [J]. Chinese Journal of Dermatology, 2025, 58(7): 679-682. |
[3] | Chen Yuhong, Lyu Zhongfa. Regulatory mechanisms underlying the hair cycle [J]. Chinese Journal of Dermatology, 2025, 58(7): 686-690. |
[4] | Yang Jie, Liu Liping. Application of single-cell sequencing in the hair research [J]. Chinese Journal of Dermatology, 2025, 58(7): 690-694. |
[5] | Lin Jinran, Leong Hiochon, Liu Qingmei, Wu Wenyu. Androgenetic alopecia and metabolic syndrome: from mechanisms to treatment strategies [J]. Chinese Journal of Dermatology, 2025, 58(7): 591-594. |
[6] | Shen Linxia¹, Zhao Huijuan, Lin Jinran¹, Liu Qingmei, Ren Shifang, Wu Wenyu¹, . Characteristics of serum immunoglobulin G N-glycans in male patients with androgenetic alopecia [J]. Chinese Journal of Dermatology, 2025, 58(7): 595-602. |
[7] | Yang Kai, Lin Jinran, Zhu Fei, Feng Suyun, Li Zheng, Zhang Yue, Hu Ruiming, Cheng Hanxiao, Zhou Zhentao, Wu Yatong, Yang Dingquan, Zhang Jufang, Wu Wenyu, . Efficacy and safety of a domestic hair follicle extraction system in extracting hair follicles from patients with androgenetic alopecia: a multicenter, prospective, randomized, self-controlled clinical trial [J]. Chinese Journal of Dermatology, 2025, 58(7): 603-607. |
[8] | Lyu Shuying, Wang Ying, Lin Wenjun, Yang Dingquan. Efficacy of combination therapy with tofacitinib in the treatment of alopecia ophiasis: a retrospective analysis of 21 cases [J]. Chinese Journal of Dermatology, 2025, 58(7): 630-635. |
[9] | Ding Weiyun, Lin Jinran, Liu Qingmei, Zhang Yue, Yang Kai, Ni Chunya, Wu Wenyu, . Role of stem cells in scalp aging and related therapeutic strategies [J]. Chinese Journal of Dermatology, 2025, 58(7): 671-675. |
[10] | Wang Qin, Lin Jinran, Liu Qingmei, Wu Wenyu, . Oral minoxidil in the treatment of alopecia areata [J]. Chinese Journal of Dermatology, 2025, 58(7): 653-656. |
[11] | Li Yu, Wang Ziwei, Ye Rongjia, Li Rong, Zhu Yan, Zhang Xiaohua, Huang Dan, Ju Mei. Home-based phototherapy implementation and management needs in patients with vitiligo: a questionnaire survey analysis [J]. Chinese Journal of Dermatology, 2025, 58(7): 608-612. |
[12] | Shen Yuqing, Song Xiuzu. Ultraviolet and androgenetic alopecia [J]. Chinese Journal of Dermatology, 2025, 58(7): 676-678. |
[13] | Li Xiangqian, Zhang Jianzhong, Zhou Cheng. Advances in the clinical research on systemic small-molecule drugs and biologics for the treatment of alopecia areata [J]. Chinese Journal of Dermatology, 2025, 58(7): 646-649. |
[14] | Wang Qin, Ni Chunya, Yang Kai, Lin Jinran, Wu Wenyu, . Application of low-dose oral minoxidil in the treatment of androgenetic alopecia [J]. Chinese Journal of Dermatology, 2025, 58(7): 657-660. |
[15] | Zhang Li, Song Xiuzu. Role of vascular endothelial growth factor in androgenetic alopecia [J]. Chinese Journal of Dermatology, 2025, 58(7): 683-685. |
|